Portfolio List

Adaptive Biotechnologies

Adaptive Biotechnologies went IPO in 2019

Adaptive Biotechnologies is commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.

Read More

Agralogics

Agralogics provides a data platform for Food and Water Enterprises to improve their operational efficiency through tools to improve in-field collaboration, regulatory compliance, and resource conservation. Using Data Science, Flexible Mobile and Insight and Operational Dashboards, Agralogics provides quantified savings to these Enterprises for their global operations.
 
Agralogics mission is to enable Food and Water Enterprises to improve their operational efficiency and sustainability using actionable data and information.

Read More

Aquantia

Aquantia, a fabless semiconductor company, raised $61.4M in its initial public offering on Friday November 3, 2017 issuing 6.8 million shares priced at $9/share.  The stock closed up nearly 6% at $9.51. Aquantia makes high-speed integrated circuits that help transfer massive amounts of information inside data centers.

Read more about it here and here

Read More

Atheer Labs

Atheer is a revolutionary wearable technology company that is creating an immersive mobile 3D platform that allows users to interact with their technology in ways previously not possible.

Read More

BaseHealth

BaseHealth was acquired by Genalyte in March 2020.

BaseHealth makes an integrated health management platform called Genophen. The company leverages the broad appeal of genomics to engage patients with their physicians in a highly-collaborative way.

Read More

Bright Context

Bright Context was acquired by Wealth Engine in 2014. Read more here
Bright Context provides a massively scalable data stream processing platform that makes it easy to deliver real-time stream analytics from any data source.

Read More

Cellanome

Cellanome is developing a unique multiomics platform to measure biology at an unprecedented resolution and scale. Central to this vision is our proprietary technology, as well as cutting edge synthetic biology and informatics methods.

Read More

Clear Labs

Clear Labs is the standard for molecular food quality in the global food industry. We are pioneering food analytics to so that the world’s most respected brands can differentiate on quality and stand behind their value.

Read More

Clever Sense

Clever Sense was acquired by Google, Inc (GOOG) in 2011.
Clever Sense developed a context-aware personalization platform that helps people find things around them that match their tastes, using our machine learning & data mining technologies.

Read More

Color Genomics, Inc.

Color provides high-quality, physician-ordered, genetic testing at a low cost. We include support for physicians, as well as genetic counseling as part of every purchase. Our goal is to expand physician-supported access to genetic testing to help every person, everywhere understand their risk for hereditary disorders.

Read More

COMPLIANCE.AI

Archer, an enterprise leader in providing a fully integrated risk management solution, acquired Compliance.ai, a leading provider of artificial intelligence (AI)-driven regulatory change management solutions in February 2024.

Compliance.ai’s mission is to transform the way highly regulated organizations address compliance risk and to modernize compliance processes for both regulators and regulated entities.

Compliance.ai delivers regulatory change management (RCM) solutions designed specifically for firms in the banking, financial services, and insurance industry (BFSI). Our unique Expert-In-The-Loop methodology ensures expert oversight of advanced machine learning technologies simplify and streamline complex RCM and compliance activities for our clients.

Read More

DeepSight Technology

DeepSight Technology founded in 2019 by Nader Sadrzadeh, Lan Yang, and Anand Chandrasekher with the vision to revolutionize medical imaging using a proprietary sensing technology. With offices in San Francisco Bay Area and Clayton, Missouri, DeepSight aims to vastly extend the range of diagnostic medical ultrasound to benefit public health and well-being.

Read More

insitro

At insitro, we are building a different kind of drug company to bring better drugs faster to the patients who can benefit most. Through the power of machine learning (ML) and data at scale, we decode the complexities of biology to unlock transformative new medicines.

Read More

IntegenX

IntegenX was acquired by Thermo Fisher Scientific in March 2018.

IntegenX provides integrated systems enabling microsample preparation and analysis for the life sciences.

Read More